Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland

Kenfak-Foguena, Alain; Schöni-Affolter, Franziska; Bürgisser, Phillippe; Witteck, Andrea; Darling, Katharine E A; Kovari, Helen; Kaiser, Laurent; Evison, John-Marc; Elzi, Luigia; Gurter-De La Fuente, Vanina; Jost, Josef; Moradpour, Darius; Abravanel, Florence; Izpopet, Jacques; Cavassini, Matthais (2011). Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerging infectious diseases, 17(6), pp. 1074-1078. Atlanta, Ga.: U.S. National Center for Infectious Diseases 10.3201/eid1706.101067

[img]
Preview
Text
10-1067.pdf - Published Version
Available under License BORIS Standard License.

Download (403kB) | Preview

We screened 735 HIV-infected patients in Switzerland with unexplained alanine aminotransferase elevation for hepatitis E virus (HEV) immunoglobulin G. Although HEV seroprevalence in this population is low (2.6%), HEV RNA can persist in patients with low CD4 cell counts. Findings suggest chronic HEV infection should be considered as a cause of persistent alanine aminotransferase elevation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Evison, John Marc

ISSN:

1080-6040

Publisher:

U.S. National Center for Infectious Diseases

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:24

Last Modified:

23 Jul 2015 11:52

Publisher DOI:

10.3201/eid1706.101067

PubMed ID:

21749774

Web of Science ID:

000291229600020

BORIS DOI:

10.7892/boris.8275

URI:

https://boris.unibe.ch/id/eprint/8275 (FactScience: 213792)

Actions (login required)

Edit item Edit item
Provide Feedback